Scancell (SCLP.L) shows exciting promise in the treatment of melanoma
Автор: ContentCarnivores
Загружено: 2017-02-21
Просмотров: 302
Описание:
Scancell is a UK-based, cancer-focused, biotechnology company. Zacks Analyst John Vandermosten believes Scancell has shown exciting promise in the treatment of melanoma. Their drug triggers the patient’s own immune system to eradicate tumor cells, resulting in a 95% survival rate in the ongoing trial. Scancell has an impressive portfolio consisting of two platforms, and three compounds covering five cancer indications. Vandermosten sees strong evidence for a viable and attractive platform and cancer therapy which should be very attractive to major pharmaceutical partners.
To see full report:
http://buff.ly/2kSEfVN
buff.ly/2lsr0eB
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
